These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 12490691)

  • 1. Echinocandins--an advance in the primary treatment of invasive candidiasis.
    Walsh TJ
    N Engl J Med; 2002 Dec; 347(25):2070-2. PubMed ID: 12490691
    [No Abstract]   [Full Text] [Related]  

  • 2. Caspofungin versus amphotericin B for invasive candidiasis.
    Brown AL; Greig JR
    N Engl J Med; 2003 Mar; 348(13):1287-8; author reply 1287-8. PubMed ID: 12660396
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of caspofungin and amphotericin B for invasive candidiasis.
    Mora-Duarte J; Betts R; Rotstein C; Colombo AL; Thompson-Moya L; Smietana J; Lupinacci R; Sable C; Kartsonis N; Perfect J;
    N Engl J Med; 2002 Dec; 347(25):2020-9. PubMed ID: 12490683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caspofungin versus amphotericin B for the treatment of Candidal esophagitis.
    Chocarro Martínez A; Gonzalez A; Garcia I
    Clin Infect Dis; 2002 Jul; 35(1):107; author reply 107-8. PubMed ID: 12060888
    [No Abstract]   [Full Text] [Related]  

  • 5. Successful treatment with caspofungin of hepatosplenic candidiasis resistant to liposomal amphotericin B.
    Sorà F; Chiusolo P; Piccirillo N; Pagano L; Laurenti L; Farina G; Sica S; Leone G
    Clin Infect Dis; 2002 Nov; 35(9):1135-6. PubMed ID: 12384850
    [No Abstract]   [Full Text] [Related]  

  • 6. Caspofungin in combination with amphotericin B against Candida glabrata.
    Barchiesi F; Spreghini E; Fothergill AW; Arzeni D; Greganti G; Giannini D; Rinaldi MG; Scalise G
    Antimicrob Agents Chemother; 2005 Jun; 49(6):2546-9. PubMed ID: 15917570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment of Candida krusei fungemia with amphotericin B and caspofungin.
    Olver WJ; Scott F; Shankland GS
    Med Mycol; 2006 Nov; 44(7):655-7. PubMed ID: 17071561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment with caspofungin of refractory Candida krusei candidemia in a very low birth weight preterm infant.
    Natale F; Castronovo A; Regoli D; De Curtis M; Manzoni P
    Pediatr Infect Dis J; 2009 May; 28(5):452. PubMed ID: 19295457
    [No Abstract]   [Full Text] [Related]  

  • 9. Successful treatment of Candida krusei infection with caspofungin acetate: a new antifungal agent.
    McGee WT; Tereso GJ
    Crit Care Med; 2003 May; 31(5):1577-8. PubMed ID: 12771636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Successful treatment with caspofungin of an invasive candidosis resistant to liposomal amphotericin B in a neutropenic patient].
    Rome A; André N; Michel A; Coze C; Gentet JC; Bernard JL
    Arch Pediatr; 2006 Dec; 13(12):1556-7. PubMed ID: 17049216
    [No Abstract]   [Full Text] [Related]  

  • 11. Caspofungin for refractory candidemia in neonates.
    Manzar S; Kamat M; Pyati S
    Pediatr Infect Dis J; 2006 Mar; 25(3):282-3. PubMed ID: 16511405
    [No Abstract]   [Full Text] [Related]  

  • 12. Development of candidemia on caspofungin therapy: a case report.
    Cheung C; Guo Y; Gialanella P; Feldmesser M
    Infection; 2006 Dec; 34(6):345-8. PubMed ID: 17180591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global distribution and outcomes for Candida species causing invasive candidiasis: results from an international randomized double-blind study of caspofungin versus amphotericin B for the treatment of invasive candidiasis.
    Colombo AL; Perfect J; DiNubile M; Bartizal K; Motyl M; Hicks P; Lupinacci R; Sable C; Kartsonis N
    Eur J Clin Microbiol Infect Dis; 2003 Aug; 22(8):470-4. PubMed ID: 12884068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antifungal pharmacotherapy for neonatal candidiasis.
    Bliss JM; Wellington M; Gigliotti F
    Semin Perinatol; 2003 Oct; 27(5):365-74. PubMed ID: 14626500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invasive candidiasis in cancer patients: observations from a randomized clinical trial.
    DiNubile MJ; Hille D; Sable CA; Kartsonis NA
    J Infect; 2005 Jun; 50(5):443-9. PubMed ID: 15907554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Echinocandins for candidemia in adults without neutropenia.
    Bennett JE
    N Engl J Med; 2006 Sep; 355(11):1154-9. PubMed ID: 16971721
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy of micafungin for the treatment of candidemia.
    Andes D; Safdar N
    Eur J Clin Microbiol Infect Dis; 2005 Oct; 24(10):662-4. PubMed ID: 16247615
    [No Abstract]   [Full Text] [Related]  

  • 18. Voriconazole for candidosis: an important addition?
    Graybill JR
    Lancet; 2005 Oct 22-28; 366(9495):1413-4. PubMed ID: 16243074
    [No Abstract]   [Full Text] [Related]  

  • 19. A randomized double-blind study of caspofungin versus amphotericin for the treatment of candidal esophagitis.
    Villanueva A; Arathoon EG; Gotuzzo E; Berman RS; DiNubile MJ; Sable CA
    Clin Infect Dis; 2001 Nov; 33(9):1529-35. PubMed ID: 11588698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible hepatosplenic candidiasis treated with liposomal amphotericin B and caspofungin combination.
    Arda B; Soyer N; Sipahi OR; Hüdaverdi O; Tasbakan MI; Saydam G; Tombuloglu M
    J Infect; 2006 May; 52(5):387-8. PubMed ID: 16181678
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.